For many UK high-growth technology and life sciences enterprises the US is a highly attractive place to expand and raise later-stage funding than the United States. The US offers the promise of massive commercial opportunities and plentiful venture and growth capital. However, doing business and raising money in this highly-competitive environment with very different dynamics to the UK requires thoughtful advance planning and clinical execution.
In this facilitated Q&A session, we will discuss best practices for navigating the logistical aspects of launching and operating a UK business in the States, and setting, as well as meeting expectations for US later-stage funding.
The discussion will be led by Daniel Glazer, who leads the US Expansion group at Silicon Valley-headquartered Wilson Sonsini. Dan divides his time between London and New York, assisting technology-driven UK companies with US expansion, fundraising and strategic partnership transactions. Also joining will be New York-based Wilson Sonsini partner Megan Baier, who advises UK and US life sciences, healthcare and digital health companies on US IPOs, VC financings, and M&A transactions.
Here’s a sample of various frequently-asked questions:
- When should I seriously consider establishing US operations?
- When should I look to raise money from US VCs?
- Do I need a US company to raise money from US VCs?
- When do I need to create a US company?
- Where is the best place to set up in the States?
- How long does US set up take and how much does it cost?
- How do I sell/pitch in the US as a British/non-US founder?
- How is hiring different in the US, and what’s the optimal US team?
- Does everyone really sue each other all the time in the US?
- Are there government resources to assist with US expansion?
5 June 2018 from 8:30 am
Hauser Forum, 3 Charles Babbage Road, CB3 0GT